What is Obsidian Therapeutics Inc. (OBX) stock price today?

Obsidian Therapeutics Inc. (OBX) is currently trading at $35.92, up 30.62% today.

What is OBX P/E ratio?

Obsidian Therapeutics Inc.'s P/E ratio is -13.38. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is Obsidian Therapeutics Inc.'s market cap?

Obsidian Therapeutics Inc. has a market capitalization of $37.36M.

NASDAQ · Biotechnology

Obsidian Therapeutics Inc. (OBX) Stock

$35.92 +30.62% NASDAQ: OBX Healthcare

A clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymphocyte (TIL) cell therapies for the treatment of patients with solid tumors. Its proprietary cytoDRiVE® technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.

Valuation

Metric	Value
Price	$35.92
Market Cap	$37.36M
P/E Ratio	-13.38
P/B Ratio	—
P/S Ratio	—
EPS (TTM)	$-2.13
52-Week High	$49.97
52-Week Low	$15.57
Dividend Yield	—

Financials & Margins

Metric	Value
ROE	—
ROA	—
ROCE	—
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.07
Current Ratio	4.21

Latest News

Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls The Fly · Aug 5, 2026 Obsidian Therapeutics Announces First Patient Enrolled in the Registration-enabling Cohort of Phase 1/2 Agni-01 Study Evaluating Amsoki-cel (OBX-115) in Advanced Melanoma Business Wire · Aug 5, 2026 Obsidian Therapeutics Completes Closing of Transaction with Galera Therapeutics and Previously Announced Private Placement of $350 Million Business Wire · Aug 3, 2026

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	—
FCF Yield	—
Quick Ratio	—
Interest Coverage	—
Return 1Y	—
Return 3Y	—
Return 5Y	—

Ownership

Insiders Held0.89%

Institutions Held0.13%

Institutions Float Held0.13%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
AAPLApple Inc.	$313.33	+0.29%	37.72	$4.60T	0.34%
MSFTMicrosoft Corporation	$499.99	+0.03%	22.95	$3.71T	0.94%
GOOGLAlphabet Inc.	$354.30	-0.96%	27.68	$4.29T	0.23%
AMZNAmazon.com, Inc.	$274.48	+0.82%	28.76	$2.95T	0.00%
METAMeta Platforms, Inc.	$592.10	+0.37%	21.47	$1.51T	0.35%

About Obsidian Therapeutics Inc.

Obsidian Therapeutics Inc. is headquartered in US.

Obsidian Therapeutics Inc. (OBX) stock trades at $35.92 with a market capitalization of $37.36M. The stock is valued at a price-to-earnings (P/E) ratio of -13.38. Over the past 52 weeks the stock has ranged between $15.57 and $49.97, and currently trades 28.1% below its 52-week high.

On profitability, Obsidian Therapeutics Inc. generates an operating margin of 0.00%, a net profit margin of 0.00%.

Official website: www.obsidiantx.com